S. 3452 119th Congress Senate

Biological Intellectual Property Protection Act of 2025

Official title: A bill to restrict the export to foreign entities of concern of United States intellectual property and sensitive information related to synthetic biology, and for other purposes.

Introduced: December 11, 2025 Introduced by: Tom Cotton Republican · Arkansas See on congress.gov

International Affairs Advanced technology and technological innovationsAsiaChinaData collection, sharing, protection

More subjectsShow fewer subjects

EuropeGeneticsIntellectual propertyIranLicensing and registrationsMiddle EastNorth KoreaRussiaTrade restrictionsTrade secrets and economic espionage

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Dec 11, 2025

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

Dec 11, 2025

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now December 11, 2025

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

Related & companion bills 1

Bill text 1 version

Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Banking, Housing, and Urban Affairs Committee
Senate

Lobbying activity 12

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
GSK (FKA GLAXOSMITHKLINE INC.)
for GSK (FKA GLAXOSMITHKLINE INC.) · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
AMGEN, INC.
for AMGEN INC · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
IPOLICY SOLUTIONS
for TWIST BIOSCIENCE CORPORATION · California · 3rd Quarter 2026 (July 1 - Sep 30)
AMGEN, INC.
for AMGEN INC · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)

Bodies those filers lobbied

HOUSE OF REPRESENTATIVES
12 filings
SENATE
12 filings
Centers For Medicare and Medicaid Services (CMS)
7 filings
Health & Human Services, Dept of (HHS)
7 filings
Treasury, Dept of
5 filings
Patent & Trademark Office (PTO)
4 filings
Commerce, Dept of (DOC)
3 filings
Office of Management & Budget (OMB)
3 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 12 filings →

Cosponsors 3

McCormick, David

Pennsylvania · Jun 1, 2026

Budd, Ted

North Carolina · Dec 11, 2025

Hassan, Margaret Wood

New Hampshire · Dec 11, 2025

Cite this page click to expand

APA

U.S. Congress. (2026). S. 3452: Biological Intellectual Property Protection Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-S-3452/

MLA

"S. 3452: Biological Intellectual Property Protection Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-3452/.

Bluebook (legal)

S. 3452, 119th Cong. (2026), https://openamerica.io/bill/119-S-3452/.

Markdown link

[S. 3452: Biological Intellectual Property Protection Act of 2025](https://openamerica.io/bill/119-S-3452/)